CVS HEALTH CorpCVSCash flow

Market cap
$102.2B
P/E ratio
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Depreciation & amortization-------2,4792,7184,3714,4414,5124,2474,3664,597
Stock-based compensation150135132141165230222234280453400484447588540
Cash from operations 4,7795,8566,6715,7838,1378,41210,0698,0078,86512,84815,86518,26516,17713,4269,107
Capital expenditures-2,005-1,872-2,030-1,984-2,136-2,367-2,224-1,918-2,037-2,457-2,437-2,520-2,727-3,031-2,781
Cash from investing -1,640-2,410-1,849-1,835-4,045-13,420-2,470-2,932-43,285-3,339-5,534-5,261-5,047-20,889-7,613
Payments for dividends 4796748291,0971,2881,5761,8402,0492,0382,6032,6242,6252,9073,1323,373
Repurchases of common stock1,5003,0014,3303,9764,0015,0014,4614,361----3,5002,0123,023
Proceeds from issuance of term debt, net9911,4631,2393,9641,48314,8053,455-44,3433,7369,958987-10,8987,913
Repayments of term debt2,1032,1221,718-3,1002,9025,943-5,5228,33615,63110,2544,2113,1664,773
Cash from financing -2,798-3,460-4,860-1,237-5,6945,006-6,689-6,75136,819-7,850-8,155-11,356-10,5162,683-1,135
Free cash flow
FCF margin (%)